Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 3 5Phase 1 2Phase NA 1Phase 1/2 1

Status

Completed 3Unknown 2

Sponsor Class

NIH 3OTHER 1NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 17CNS 10Plasma cell 5Sarcoma 3Other hematologic neoplasm 3Breast 2Myeloid 1

Conditions

Multiple Myeloma 5Neoplasms, Plasma Cell 2Neoplasms 1

Interventions

Dexamethasone 177Bortezomib 98Lenalidomide 90daratumumab 46Melphalan 45Thalidomide 44pomalidomide 42Cyclophosphamide 38Calcium Dobesilate 30carfilzomib 29Prednisone 19Doxorubicin 16elotuzumab 14Filgrastim 14ixazomib 11isatuximab 11Granulocyte Colony-Stimulating Factor 11Vincristine 10Peripheral Blood Stem Cell Transplantation 10dexamethasone acetate 9belantamab mafodotin 9Zoledronic Acid 8selinexor 7Epoetin Alfa 7fludarabine 6Etoposide 6dexamethasone 21-phosphate 5auricularum 5Mycophenolic Acid 5Cisplatin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Carmustine × Plasma cell × Clear all
NCT00083551 2015-11-23

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

University of Arkansas

Phase 3 Completed
668 enrolled 7 charts
Plasma cell

Multiple Myeloma, Neoplasms

NCT00002548 2015-03-06

SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma

SWOG Cancer Research Network

Phase 3 Completed
899 enrolled
Plasma cell

Multiple Myeloma

NCT00002599 2013-12-19

Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma

National Cancer Institute (NCI)

Phase 3 Unknown
750 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00002653 2013-12-19

Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma

National Cancer Institute (NCI)

Phase 3 Unknown
1,000 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00002556 2013-05-31

Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma

National Cancer Institute (NCI)

Phase 3 Completed
312 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡